EASTMAN CHEMICAL CO
For the period ended Sep 30, 2026. Filed Oct 30, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 30, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Summary by Operating Segment
Table of Contents
SUMMARY BY OPERATING SEGMENT
Eastman's products and operations are managed and reported in four operating segments: Advanced Materials ("AM"), Additives & Functional Products ("AFP"), Chemical Intermediates ("CI"), and Fibers. For additional financial and product information for each operating segment, see Part I, Item 1, "Business - Business Segments" and Part II, Item 8, Note 20, "Segment and Regional Sales Information", in the Company's 2025 Annual Report on Form 10-K.
Advanced Materials Segment
| Third Quarter · First Nine Months | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Change · Change | ||||||||||||
| 2026 · 2025 · $ · % · 2026 · 2025 · $ · % | ||||||||||||
| (Dollars in millions) | ||||||||||||
| Sales | $762 | $728 | $34 | 5% | $2,294 | $2,224 | $70 | 3% | ||||
| Volume / product mix effect | 3 | —% | 29 | 1% | ||||||||
| Price effect | 25 | 4% | 2 | —% | ||||||||
| Exchange rate effect | 6 | 1% | 39 | 2% | ||||||||
| Earnings before interest and taxes | $103 | $41 | $62 | 151% | $272 | $278 | $(6) | (2)% | ||||
| Cost of sales impact from restructuring activities | — | 2 | (2) | 3 | 2 | 1 | ||||||
| Asset impairments, restructuring, and other charges, net | — | 10 | (10) | 6 | 10 | (4) | ||||||
| Earnings before interest and taxes excluding non-core items | 103 | 53 | 50 | 94% | 281 | 290 | (9) | (3)% | ||||
Sales revenue increased in third quarter 2026 compared to third quarter 2025 due to higher selling prices and a favorable foreign currency exchange impact. Higher selling prices in the specialty plastics product line were due to higher raw material and distribution prices.
Sales revenue increased in first nine months 2026 compared to first nine months 2025 due to a favorable foreign currency exchange impact and higher sales volume mix.
EBIT increased in third quarter 2026 compared to third quarter 2025 primarily due to approximately $60 million improved asset utilization and lower planned maintenance costs.
EBIT in first nine months 2026 included inventory adjustments and asset impairments, restructuring, and other charges, net related to the closure of a production line at a German performance films facility. EBIT in third quarter and first nine months 2025 included inventory adjustments and asset impairments, restructuring, and other charges, net related to the decommissioning of certain assets at performance films facilities in North America. For more information see Note 11, "Asset Impairments, Restructuring, and Other Charges, Net", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.
Excluding these non-core items, EBIT decreased in first nine months 2026 compared to first nine months 2025 due to $35 million lower selling prices, net of higher raw material and energy costs, which were mostly offset by a favorable foreign currency exchange impact.
Table of Contents
Additives & Functional Products Segment
| Third Quarter · First Nine Months | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Change · Change | ||||||||||||
| 2026 · 2025 · $ · % · 2026 · 2025 · $ · % | ||||||||||||
| (Dollars in millions) | ||||||||||||
| Sales | $784 | $716 | $68 | 9% | $2,330 | $2,218 | $112 | 5% | ||||
| Volume / product mix effect | (4) | (1)% | (16) | (1)% | ||||||||
| Price effect | 71 | 10% | 90 | 4% | ||||||||
| Exchange rate effect | 1 | —% | 38 | 2% | ||||||||
| Earnings before interest and taxes | $154 | $128 | $26 | 20% | $447 | $418 | $29 | 7% | ||||
| Asset impairments, restructuring, and other charges, net | — | — | — | — | 4 | (4) | ||||||
| Earnings before interest and taxes excluding non-core item | 154 | 128 | 26 | 20% | 447 | 422 | 25 | 6% | ||||
Sales revenue increased in third quarter 2026 compared to third quarter 2025 due to higher selling prices which were mostly driven by cost-pass-through contracts.
Sales revenue increased in first nine months 2026 compared to first nine months 2025 primarily due to higher selling prices and a favorable foreign currency exchange impact. Higher selling prices were driven by cost-pass-through contracts.
EBIT increased in third quarter 2026 compared to third quarter 2025 due to $21 million higher selling prices, net of higher raw material and distribution costs and improved asset utilization
EBIT in first nine months 2025 included asset impairments, restructuring, and other charges, net related to the closure of a heat-transfer fluids production line at a specialty fluids and energy facility in North America. For more information see Note 11, "Asset Impairments, Restructuring, and Other Charges, Net", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.
Excluding this non-core item, EBIT increased in first nine months 2026 compared to first nine months 2025 due to $14 million higher selling prices, net of higher raw material, energy, and distribution costs and a favorable foreign currency exchange impact.
Table of Contents
Chemical Intermediates Segment
| Third Quarter · First Nine Months | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Change · Change | ||||||||||||
| 2026 · 2025 · $ · % · 2026 · 2025 · $ · % | ||||||||||||
| (Dollars in millions) | ||||||||||||
| Sales | $580 | $499 | $81 | 16% | $1,718 | $1,507 | $211 | 14% | ||||
| Volume / product mix effect | 22 | 4% | 126 | 8% | ||||||||
| Price effect | 58 | 12% | 73 | 5% | ||||||||
| Exchange rate effect | 1 | —% | 12 | 1% | ||||||||
| Earnings (loss) before interest and taxes | $35 | $1 | $34 | >100% | $75 | $(10) | $85 | >100% | ||||
Sales revenue increased in third quarter and first nine months 2026 compared to third quarter and first nine months 2025 due to higher sales volume mix and higher selling prices, particularly for olefin and derivative products. These increases were driven by increased volume availability compared to the prior year period and tight market conditions due to the ongoing conflict in the Middle East.
EBIT increased in third quarter and first nine months 2026 compared to third quarter and first nine months 2025 primarily due to higher selling prices, net of higher raw material and distribution costs.
Fibers Segment
| Third Quarter · First Nine Months | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Change · Change | ||||||||||||
| 2026 · 2025 · $ · % · 2026 · 2025 · $ · % | ||||||||||||
| (Dollars in millions) | ||||||||||||
| Sales | $255 | $254 | $1 | —% | $723 | $816 | $(93) | (11)% | ||||
| Volume / product mix effect | 9 | 4% | (66) | (7)% | ||||||||
| Price effect | (9) | (4)% | (30) | (4)% | ||||||||
| Exchange rate effect | 1 | —% | 3 | —% | ||||||||
| Earnings before interest and taxes | $52 | $67 | $(15) | (22)% | $133 | $236 | $(103) | (44)% | ||||
Sales revenue remained relatively unchanged in third quarter 2026 compared to third quarter 2025 as higher sales volume mix was offset by lower selling prices. Higher sales volume mix was due to increased sales of textiles and acetyl chemical products. Lower selling prices were due to lower acetate tow contract pricing.
Sales revenue decreased in first nine months 2026 compared to first nine months 2025 due to lower sales volume mix and lower selling prices.
EBIT decreased in third quarter 2026 compared to third quarter 2025 due to lower selling prices, net of higher raw material and distribution costs.
EBIT decreased in first nine months 2026 compared to first nine months 2025 due to lower sales volume mix and lower selling prices, net of higher raw material, energy, and distribution costs.
Table of Contents
Other
| Third Quarter | First Nine Months | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| (Dollars in millions) | ||||
| Sales | $4 | $5 | $10 | $14 |
| Loss before interest and taxes | ||||
| Growth initiatives and businesses not allocated to operating segments | $(39) | $(41) | $(117) | $(139) |
| Pension and other postretirement benefits income (expense), net not allocated to operating segments | 6 | 2 | 20 | 4 |
| Asset impairments, restructuring, and other charges, net | — | (10) | (4) | (28) |
| Other income (charges), net not allocated to operating segments | (6) | — | (22) | (47) |
| Loss before interest and taxes | $(39) | $(49) | $(123) | $(210) |
| Asset impairments, restructuring, and other charges, net | — | 10 | 4 | 28 |
| Environmental and other costs | — | — | 8 | 40 |
| Loss before interest and taxes excluding non-core items | (39) | (39) | (111) | (142) |
Sales and costs related to growth initiatives, including the cellulosic biopolymer and circular economy platforms, R&D costs, certain components of pension and other postretirement benefits, and other expenses and income not identifiable to an operating segment are included in "Other".
Loss before interest and taxes in first nine months 2026 and first nine months 2025 included environmental and other costs from previously divested or non-operational sites and product lines, and severance charges related to corporate cost reduction initiatives. First nine months 2026 also included associated gains and losses. Third quarter 2025 included severance charges related to corporate cost reduction initiatives. For more information regarding non-GAAP items, see "Non-GAAP Financial Measures" in this MD&A. For more information regarding asset impairments, restructuring, and other charges, net, see Note 11, "Asset Impairments, Restructuring, and Other Charges, Net", to the unaudited consolidated financial statements in Part I, Item 1 of this Quarterly Report.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.